| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | LION BIOTECHNOLOGIES INC COM | 53,157 | 396,000 | 0.29% | ||
| 52 | LIGAND PHARMACEUTICALS INC | 3,719 | 394,000 | 0.29% | ||
| 53 | MYRIAD GENETICS INC | 20,484 | 393,000 | 0.29% | ||
| 54 | GILEAD SCIENCES INC | 5,737 | 390,000 | 0.29% | ||
| 55 | AKEBIA THERAPEUTICS INC | 42,019 | 387,000 | 0.29% | ||
| 56 | BIO TECHNE CORP | 3,790 | 385,000 | 0.29% | ||
| 57 | ACADIA PHARMACEUTICALS INC COM | 11,130 | 383,000 | 0.28% | ||
| 58 | AVEXIS INC COM | 5,000 | 380,000 | 0.28% | ||
| 59 | INTERCEPT PHARMACEUTICALS INCORPORATED | 3,312 | 375,000 | 0.28% | ||
| 60 | UNITED THERAPEUTICS CORP DEL | 2,756 | 373,000 | 0.28% | ||
| 61 | ALDER BIOPHARMACEUTICALS INC | 17,858 | 371,000 | 0.28% | ||
| 62 | SCYNEXIS INC | 133,216 | 368,000 | 0.27% | ||
| 63 | INTREXON CORPORATION | 18,411 | 365,000 | 0.27% | ||
| 64 | BIOVERATIV INC | 5,587 | 304,000 | 0.23% | ||
| 65 | Axovant Sciences LTD | 17,425 | 260,000 | 0.19% | ||
| 66 | STEMLINE THERAPEUTICS INC | 20,595 | 176,000 | 0.13% | ||
| 67 | SERES THERAPEUTICS INC | 14,000 | 158,000 | 0.12% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-17-002785, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
